principles and practice of radiation therapy chapter 4 overview of radiobiology copyright © 2010 by...
TRANSCRIPT
Principles and Practice of Principles and Practice of Radiation TherapyRadiation Therapy
Chapter 4Chapter 4
Overview of RadiobiologyOverview of Radiobiology
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 22
Review of Cell BiologyReview of Cell Biology
Cytology is the study of the structure and Cytology is the study of the structure and function of the cellfunction of the cell
The human body contains both somatic and The human body contains both somatic and sex cellssex cells
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 33
Review of Cell BiologyReview of Cell Biology
Inorganic Inorganic componentscomponents HOH HOH
• 70%-80%70%-80%
SaltsSalts• Potassium inside cellPotassium inside cell
• Sodium outside cellSodium outside cell
Organic componentsOrganic components ProteinsProteins
• 15%15%
• Monomers vs. Monomers vs. polymerspolymers
• Amino acidsAmino acids
CarbohydratesCarbohydrates• 1%1%
Nucleic AcidNucleic Acid• RNA and DNARNA and DNA
LipidsLipids
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 44
Cellular StructureCellular Structure
CytoplasmCytoplasm Cell membraneCell membrane Endoplasmic reticulumEndoplasmic reticulum RibosomeRibosome MitochondriaMitochondria LysosomeLysosome Golgi complexGolgi complex
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 55
Cellular StructureCellular Structure
NucleusNucleus DNADNA
• Nitrous basesNitrous bases
• PurinesPurines AdenineAdenine GuanineGuanine
• PyrimidinesPyrimidines ThymineThymine CytosineCytosine
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 66
MitosisMitosis
ProphaseProphase MetaphaseMetaphase AnaphaseAnaphase TelophaseTelophase
InterphaseInterphase G0G0 G1G1 SS G2G2
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 77
RadiobiologyRadiobiology
The study of the sequence of events following The study of the sequence of events following the absorption of energy from ionizing the absorption of energy from ionizing radiation, the efforts of the organism to radiation, the efforts of the organism to compensate, and the damage to the compensate, and the damage to the organism that may be producedorganism that may be produced
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 88
Interactions of Interactions of Radiation and MatterRadiation and Matter
Direct actionDirect action Radiation interacts with the targetRadiation interacts with the target
Indirect actionIndirect action Radiation interacts with something else that Radiation interacts with something else that
eventually causes an interaction with the targeteventually causes an interaction with the target• Typically HOHTypically HOH
• More common than directMore common than direct
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 99
Indirect ActionIndirect Action
Free radicalFree radical An atom or molecule with an unpaired electron An atom or molecule with an unpaired electron
and no chargeand no charge Very reactiveVery reactive
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 1010
Free Radical ProductionFree Radical Production
HOH + ionizing radiation HOH + ionizing radiation HOHHOH++ + e + e--
Can rejoin without damageCan rejoin without damage ee-- can bond with HOH can bond with HOH
• HOH + eHOH + e-- HOHHOH--
Both products disassociateBoth products disassociate HOHHOH++ H H++ + OH + OH HOHHOH-- OH OH-- + H + H
– represents a free radicalrepresents a free radical Typically the HTypically the H++ and OH and OH-- rejoin to form HOH with no rejoin to form HOH with no
damagedamage
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 1111
Free Radical ProductionFree Radical Production
Interactions of free radicalsInteractions of free radicals Possible resultsPossible results
• HH+ OH+ OH HOH HOH
• HH+ H+ HHH22
• OHOH+ OH+ OH H H22OO22
• Join with other normal moleculeJoin with other normal molecule HH+ O+ O22
HOHO22
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 1212
Linear Energy Transfer (LET)Linear Energy Transfer (LET)
A measure of the energy transferred or A measure of the energy transferred or deposited into a material as an ionizing deposited into a material as an ionizing particle travels through the materialparticle travels through the material Low LETLow LET
• X and gamma raysX and gamma rays
Moderate LETModerate LET• NeutronsNeutrons
High LETHigh LET• Alpha particlesAlpha particles
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 1313
Relative Biologic Effectiveness Relative Biologic Effectiveness (RBE)(RBE)
A comparison of doses between a standard A comparison of doses between a standard radiation (250 kV, x-rays) and a test radiation radiation (250 kV, x-rays) and a test radiation (R) that yield the same biologic result(R) that yield the same biologic result RBE = DRBE = D250250/D/DRR
As LET increases, RBE increasesAs LET increases, RBE increases
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 1414
Oxygen Enhancement Ratio Oxygen Enhancement Ratio (OER)(OER)
A numeric representation of the dose A numeric representation of the dose comparison for a given biologic effect in comparison for a given biologic effect in anoxic and aerobic conditionsanoxic and aerobic conditions OER = DOER = Danoxicanoxic/D/Daerobicaerobic
As LET and RBE increase, OER decreasesAs LET and RBE increase, OER decreases
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 1515
Radiation Effects on DNARadiation Effects on DNA
RepairRepair Base damageBase damage
Loss or change of a baseLoss or change of a base Single-strand breakSingle-strand break Double-strand breakDouble-strand break Cross-linkingCross-linking
An abnormal bond between DNA strands or An abnormal bond between DNA strands or proteinsproteins
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 1616
Radiation Effects on Radiation Effects on ChromosomesChromosomes
Any change is considered an aberration, Any change is considered an aberration, lesion, or anomalylesion, or anomaly Chromosome aberration vs. chromatid aberrationChromosome aberration vs. chromatid aberration
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 1717
Radiation Effects on Radiation Effects on ChromosomesChromosomes
Acentric fragmentAcentric fragment Two broken ends without a centromereTwo broken ends without a centromere
Dicentric chromatidDicentric chromatid Two chromosomes with broken ends join, resulting Two chromosomes with broken ends join, resulting
in one chromosome with two centromeresin one chromosome with two centromeres RingRing TranslocationTranslocation InversionInversion DeletionDeletion
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 1818
Radiation Effects on Other Cell Radiation Effects on Other Cell ComponentsComponents
Cell membraneCell membrane Changes in the permeabilityChanges in the permeability
MitochondriaMitochondria LysosomeLysosome
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 1919
Cellular Response to RadiationCellular Response to Radiation
In vivo means in the organismIn vivo means in the organism Can observe the effects of radiation only on skin Can observe the effects of radiation only on skin
and hematopoietic systemand hematopoietic system In vitro means in glasswareIn vitro means in glassware
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 2020
Fate of Irradiated CellsFate of Irradiated Cells
No damageNo damage Division delay or mitotic delayDivision delay or mitotic delay
Cell is held in G2 before entering mitosisCell is held in G2 before entering mitosis Mitotic overshootMitotic overshoot
Interphase deathInterphase death Dose dependentDose dependent
Reproductive failureReproductive failure Cell fails to enter mitosisCell fails to enter mitosis
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 2121
Cell Survival CurveCell Survival Curve
Describes the relationship between dose and Describes the relationship between dose and the percentage of surviving cellsthe percentage of surviving cells
Based on experimental dataBased on experimental data Suggests that there are two mechanisms for Suggests that there are two mechanisms for
cell deathcell death Lethal single-hit killingLethal single-hit killing Accumulation of multiple sublethal hits resulting in Accumulation of multiple sublethal hits resulting in
deathdeath
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 2222
Semilogarithmic Graphing PaperSemilogarithmic Graphing Paper
Vertical axisVertical axis Logarithmic portionLogarithmic portion Represents percent survivalRepresents percent survival
Horizontal axisHorizontal axis NonlogarithmicNonlogarithmic Represents doseRepresents dose
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 2323
Cell Survival CurveCell Survival Curve
Straight line portionStraight line portion As dose doubles, the percentage surviving As dose doubles, the percentage surviving
decreases by halfdecreases by half Occurs at higher dosesOccurs at higher doses
ShoulderShoulder The initial portion of the survival curve (low dose) The initial portion of the survival curve (low dose)
does not behave like the straight line portiondoes not behave like the straight line portion Initial slope is much more shallowInitial slope is much more shallow
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 2424
Target TheoryTarget Theory DD11
Sometimes called 1DSometimes called 1D00
Represents the initial slope Represents the initial slope of the curveof the curve
DD00
Represents the terminal Represents the terminal slope or straight line slope or straight line portionportion
D37D37 Dose required to kill all but Dose required to kill all but
37% of the cells37% of the cells
DDqq
Quasithreshold doseQuasithreshold dose Extrapolation of DExtrapolation of D00 to the to the
100% line100% line NN
Extrapolation number or Extrapolation number or target numbertarget number
Extrapolation of DExtrapolation of D00 back to back to
the vertical axisthe vertical axis Thought to represent the Thought to represent the
number of targets in the cellnumber of targets in the cell
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 2525
Surviving FractionSurviving Fraction
Sometimes labeled ESometimes labeled E SF = NeSF = Ne-(D/D-(D/D00))
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 2626
Linear Quadratic ModelLinear Quadratic Model
Dual radiation action theoryDual radiation action theory Lethal single-hit killsLethal single-hit kills Accumulation of sublethal dose killsAccumulation of sublethal dose kills D: DoseD: Dose
SF = SF = D +D +DD2 2 D is the linear componentD is the linear component DD22 is the quadratic component is the quadratic component
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 2727
Linear Quadratic ModelLinear Quadratic Model
Can be rewritten to account for fractionationCan be rewritten to account for fractionation SF = SF = D[1 + d/(D[1 + d/(//)])]
d is the fraction dosed is the fraction dose [1 + d/([1 + d/(//)] is the relative effectiveness)] is the relative effectiveness //is the dose at which single-hit and multihit is the dose at which single-hit and multihit
killing are equalkilling are equal SF/SF/ is the biologic effective dose is the biologic effective dose
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 2828
Law of Bergonié and TribondeauLaw of Bergonié and Tribondeau
Cells are most radiosensitive whenCells are most radiosensitive when Actively proliferatingActively proliferating Highly metabolicHighly metabolic UndifferentiatedUndifferentiated Well nourishedWell nourished
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 2929
Law of Ancel and VitembergerLaw of Ancel and Vitemberger
Describes biologic stress and sensitivity to Describes biologic stress and sensitivity to radiationradiation
Postulates that all cells have the same Postulates that all cells have the same inherent radiosensitivity because all have the inherent radiosensitivity because all have the same targetsame target
““Radiosensitive” cells are those under Radiosensitive” cells are those under biologic stress, such as the need to dividebiologic stress, such as the need to divide
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 3030
Cell PopulationsCell Populations
Categories based on radiosensitivityCategories based on radiosensitivity Vegetative intermitotic (VIM) cellsVegetative intermitotic (VIM) cells Differentiating intermitotic (DIM) cellsDifferentiating intermitotic (DIM) cells Multipotential connective tissue (MPCT) cellsMultipotential connective tissue (MPCT) cells Reverting postmitotic (RPM) cellsReverting postmitotic (RPM) cells Fixed postmitotic (FPM) cellsFixed postmitotic (FPM) cells
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 3131
Clonogenic AssayClonogenic Assay
Investigate the cell’s ability to divideInvestigate the cell’s ability to divide In situ assayIn situ assay
Example: Intestinal crypt cellsExample: Intestinal crypt cells Measure the number of cell colonies after various Measure the number of cell colonies after various
dosesdoses Transplantation assayTransplantation assay
Example: Bone marrowExample: Bone marrow Transplant irradiated cells into a new hostTransplant irradiated cells into a new host Measure the number of cell colonies after various Measure the number of cell colonies after various
dosesdoses
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 3232
Functional AssaysFunctional Assays
Used to assess cells that do not rapidly divide Used to assess cells that do not rapidly divide by measuring function after irradiationby measuring function after irradiation Measure late effectsMeasure late effects
Results in dose-response curves rather than Results in dose-response curves rather than cell survival curvescell survival curves
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 3333
Lethality AssaysLethality Assays
Measure the number of dead organisms after a Measure the number of dead organisms after a specific dose of radiation to a specific organspecific dose of radiation to a specific organ
LDLD5050
Dose required to kill 50% of the populationDose required to kill 50% of the population Also known as median lethal doseAlso known as median lethal dose LDLD50/3050/30
• Dose required to kill 50% of population in 30 daysDose required to kill 50% of population in 30 days
TDTD5/55/5
Dose that will cause 5% of the population to have Dose that will cause 5% of the population to have effect after 5 yearseffect after 5 years
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 3434
Cellular ResponseCellular Response
Factors that alter the cellular response to Factors that alter the cellular response to radiationradiation Physical factorsPhysical factors Chemical factorsChemical factors Biologic factorsBiologic factors
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 3535
Physical Factors Affecting Physical Factors Affecting Cellular ResponseCellular Response
LET and RBELET and RBE Higher LET and RBE leads to a decrease in SFHigher LET and RBE leads to a decrease in SF High LET and RBE result in steeper shoulder and High LET and RBE result in steeper shoulder and
slopeslope Dose rateDose rate
Slower dose rates lead to increase in SFSlower dose rates lead to increase in SF Slow dose rates result in a more shallow shoulder and Slow dose rates result in a more shallow shoulder and
slopeslope High LET radiation is not affected by changes in dose High LET radiation is not affected by changes in dose
raterate
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 3636
Chemical Factors Affecting Chemical Factors Affecting Cellular ResponseCellular Response
RadiosensitizersRadiosensitizers Increase the effect of ionizing radiationIncrease the effect of ionizing radiation Presence of oxygenPresence of oxygen
• Not well understoodNot well understood
• Theorized to increase the production of free radicals or Theorized to increase the production of free radicals or prevent the repair of chemical damage following prevent the repair of chemical damage following radiationradiation
RadioresistersRadioresisters Also known as radioprotectorsAlso known as radioprotectors
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 3737
Biologic Factors Affecting Biologic Factors Affecting Cellular ResponseCellular Response
Cell cycleCell cycle Most radiosensitive in G2 and M phasesMost radiosensitive in G2 and M phases Least radiosensitive in SLeast radiosensitive in S Cell cycle is less important as dose increasesCell cycle is less important as dose increases
Intracellular repairIntracellular repair Basis for fractionationBasis for fractionation Most repair completed within 24 hoursMost repair completed within 24 hours
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 3838
Nominal Standard DoseNominal Standard Dose
Derived from isoeffect curvesDerived from isoeffect curves D = NSD × TD = NSD × T0.110.11 × N × N0.240.24
D = total doseD = total dose NSD = nominal standard doseNSD = nominal standard dose
• 1800 rets was considered standard1800 rets was considered standard T = overall treatment time in daysT = overall treatment time in days N = number of fractionsN = number of fractions
LimitationsLimitations Not useful for late-responding normal tissuesNot useful for late-responding normal tissues Does not account for volume irradiatedDoes not account for volume irradiated
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 3939
Acute vs. Late ChangesAcute vs. Late Changes
Acute effectsAcute effects The result of the depletion of parenchymal cellsThe result of the depletion of parenchymal cells
Chronic (late) effectsChronic (late) effects Primary chronic effectsPrimary chronic effects
• The result of the depletion of nonparenchymal cellsThe result of the depletion of nonparenchymal cells
Secondary chronic effectsSecondary chronic effects• Consequence of irreversible early changesConsequence of irreversible early changes
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 4040
Tissue HealingTissue Healing
RegenerationRegeneration Replacement of a dead cell with a cell with the Replacement of a dead cell with a cell with the
same functionsame function RepairRepair
Replacement of a dead cell with a different cell Replacement of a dead cell with a different cell typetype• Example: ScarExample: Scar
Both are tissue type and dose specific Both are tissue type and dose specific
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 4141
Organ-Specific EffectsOrgan-Specific Effects
Bone marrowBone marrow Reduction in number of stem cellsReduction in number of stem cells Principle of TBIPrinciple of TBI
BloodBlood Cell type specificCell type specific
• Circulating RBCs are radioresistantCirculating RBCs are radioresistant
• Lymphocytes are the most sensitiveLymphocytes are the most sensitive
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 4242
Organ-Specific EffectsOrgan-Specific Effects
SkinSkin High doses may lead to atrophy, fibrosis, High doses may lead to atrophy, fibrosis,
pigmentation changes, and/or necrosispigmentation changes, and/or necrosis Hair follicles are radiosensitiveHair follicles are radiosensitive Sweat glands are somewhat radioresistantSweat glands are somewhat radioresistant Skin-sparing effects of high-energy radiationSkin-sparing effects of high-energy radiation
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 4343
Organ-Specific EffectsOrgan-Specific Effects
Gastrointestinal tractGastrointestinal tract Moderate doses cause mucositis and esophagitisModerate doses cause mucositis and esophagitis Small bowel is the most radiosensitive GI organSmall bowel is the most radiosensitive GI organ Intestinal crypt cells or cells of LieberkühnIntestinal crypt cells or cells of Lieberkühn
• Replaced dailyReplaced daily
• Extremely high doses lead to intestinal denudingExtremely high doses lead to intestinal denuding
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 4444
Organ-Specific EffectsOrgan-Specific Effects
Male reproductive systemMale reproductive system Most tissue is radioresistant, except testesMost tissue is radioresistant, except testes Reduction in spermatogoninReduction in spermatogonin
• Also known as maturation depletionAlso known as maturation depletion
• Mature sperm is radioresistantMature sperm is radioresistant
Temporary sterility occurs after 2.5 GyTemporary sterility occurs after 2.5 Gy Permanent sterility occurs with doses greater than Permanent sterility occurs with doses greater than
6 Gy6 Gy Any dose may lead to inheritable chromosome Any dose may lead to inheritable chromosome
aberrationsaberrations
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 4545
Organ-Specific EffectsOrgan-Specific Effects
Female reproductive systemFemale reproductive system Sterility is age dependentSterility is age dependent
• Temporary sterility may occur after 6.25 GyTemporary sterility may occur after 6.25 Gy
• Radiation-induced permanent sterility will result in early-Radiation-induced permanent sterility will result in early-onset menopause onset menopause
Any dose may lead to inheritable chromosome Any dose may lead to inheritable chromosome aberrationsaberrations
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 4646
Normal Tissue Tolerance DosesNormal Tissue Tolerance Doses
Refer to Table 4-9 on page 82 of the textbook Refer to Table 4-9 on page 82 of the textbook
for tolerance doses.for tolerance doses.
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 4747
Total-Body ResponseTotal-Body Response
Conditions for radiation syndromesConditions for radiation syndromes Acute exposureAcute exposure
• Seconds to minutesSeconds to minutes
Total- or near-total-body exposureTotal- or near-total-body exposure External source of radiationExternal source of radiation
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 4848
Survival TimeSurvival Time
Life span shortening is the major effect of total-Life span shortening is the major effect of total-body exposurebody exposure Measured by LDMeasured by LD50/3050/30
Actual doses will vary by species and Actual doses will vary by species and individuals within the speciesindividuals within the species Small percentage of mammals will die after 2 GySmall percentage of mammals will die after 2 Gy Between 2 and 10 Gy, survival decreases as dose Between 2 and 10 Gy, survival decreases as dose
increasesincreases Between 10 and 100 Gy, there is little effect on Between 10 and 100 Gy, there is little effect on
survivalsurvival Above 100 Gy, survival decreases as dose Above 100 Gy, survival decreases as dose
increasesincreases
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 4949
Radiation SyndromesRadiation Syndromes
Stages of responseStages of response All patients, regardless of syndrome, experience All patients, regardless of syndrome, experience
the same stagesthe same stages• Length of stage variesLength of stage varies
ProdromalProdromal• Nausea, vomiting, diarrheaNausea, vomiting, diarrhea
LatentLatent• Patient appears to be healthyPatient appears to be healthy
Manifest illnessManifest illness• Specific syndrome presentsSpecific syndrome presents
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 5050
Hematopoietic SyndromeHematopoietic Syndrome Doses between 1 and 10 GyDoses between 1 and 10 Gy Prodromal stageProdromal stage
Begins hours after exposure and persists for days to Begins hours after exposure and persists for days to weeks (3 weeks)weeks (3 weeks)
Pancytopenia can result in infection or hemorrhagePancytopenia can result in infection or hemorrhage DeathDeath
After 2 Gy in 6-8 weeks in sensitive individualsAfter 2 Gy in 6-8 weeks in sensitive individuals After 4-6 Gy is the range of LD50/30After 4-6 Gy is the range of LD50/30 After 10 Gy, all die within 2 weeks unless given bone After 10 Gy, all die within 2 weeks unless given bone
marrow transplantmarrow transplant• Rarely successfulRarely successful
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 5151
Gastrointestinal SyndromeGastrointestinal Syndrome
Doses between 10 and 100 GyDoses between 10 and 100 Gy Death is independent of doseDeath is independent of dose
All die at same timeAll die at same time• 3-10 days without medical intervention3-10 days without medical intervention
• 2 weeks with medical intervention2 weeks with medical intervention
Death is the result of intestinal denudingDeath is the result of intestinal denuding
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 5252
Central Nervous System Central Nervous System SyndromeSyndrome
May occur at doses as low as 50 GyMay occur at doses as low as 50 Gy Latent period ends 5-6 hours postexposureLatent period ends 5-6 hours postexposure Death occurs in 2-3 daysDeath occurs in 2-3 days
Individual experiences nervousness and confusionIndividual experiences nervousness and confusion Cause of death is not well understoodCause of death is not well understood Autopsies reveal little cellular damageAutopsies reveal little cellular damage
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 5353
Embryologic EffectsEmbryologic Effects
Most sensitive during first few weeks of Most sensitive during first few weeks of developmentdevelopment
Divisions of pregnancyDivisions of pregnancy PreimplantationPreimplantation
• First 8-10 daysFirst 8-10 days
Major organogenesisMajor organogenesis• Second week to seventh weekSecond week to seventh week
FetusFetus
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 5454
Embryologic Animal StudiesEmbryologic Animal Studies
Preimplantation exposurePreimplantation exposure 200 R leads to an embryonic death rate of 80% 200 R leads to an embryonic death rate of 80%
and a 5% abnormality rateand a 5% abnormality rate Major organogenesis exposureMajor organogenesis exposure
200 R leads to an embryonic death rate of 25% 200 R leads to an embryonic death rate of 25% and a 100% abnormality rateand a 100% abnormality rate• Most abnormalities are skeletal or CNSMost abnormalities are skeletal or CNS
Fetal exposureFetal exposure 200 R yields negligible side effects200 R yields negligible side effects
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 5555
Embryologic Human StudiesEmbryologic Human Studies
Pregnant survivors of the atomic bomb Pregnant survivors of the atomic bomb Doses greater than 2 Gy resulted in 36% of Doses greater than 2 Gy resulted in 36% of
children born with mental retardationchildren born with mental retardation Doses between 0.5 and 1 Gy yielded a mental Doses between 0.5 and 1 Gy yielded a mental
retardation rate of 4.55%retardation rate of 4.55% Incidence of mental retardation in general Incidence of mental retardation in general
population is less than 1%population is less than 1%
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 5656
Somatic EffectsSomatic Effects
Effects of radiation that occur in the irradiated Effects of radiation that occur in the irradiated individual and cannot be passed on to future individual and cannot be passed on to future generationsgenerations May occur months to years postexposureMay occur months to years postexposure
A probability of developing effect exists with A probability of developing effect exists with all dosesall doses Probability increases as exposure increasesProbability increases as exposure increases Example: Smoking and lung cancerExample: Smoking and lung cancer
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 5757
CarcinogenesisCarcinogenesis
Risk associated with doses lower than 1 Gy is Risk associated with doses lower than 1 Gy is not knownnot known
Case studiesCase studies Radium dial paintersRadium dial painters Thymus irradiation in infantsThymus irradiation in infants Early medical radiation personnelEarly medical radiation personnel Uranium mine workersUranium mine workers Survivors of the atomic bombsSurvivors of the atomic bombs
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 5858
RiskRisk Absolute riskAbsolute risk
Associated with a latent period and a period of Associated with a latent period and a period of increased risk followed by a return to normal risk increased risk followed by a return to normal risk • Example: LeukemiaExample: Leukemia
Relative riskRelative risk Continuous risk throughout lifeContinuous risk throughout life Population must be followed until deathPopulation must be followed until death
Methods of estimating riskMethods of estimating risk Linear: Assume all doses have same potential for effectLinear: Assume all doses have same potential for effect Linear quadratic: Assume that dose and risk are Linear quadratic: Assume that dose and risk are
proportional proportional
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 5959
CataractogenesisCataractogenesis
Normal lens fibers are transparentNormal lens fibers are transparent Radiation damages lens cells, resulting in cataract Radiation damages lens cells, resulting in cataract
formationformation Dose is species dependentDose is species dependent Dose is patient specificDose is patient specific
May be as low as 2 Gy but all after 7 GyMay be as low as 2 Gy but all after 7 Gy Fractionated dose threshold is 12 GyFractionated dose threshold is 12 Gy
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 6060
Life Span ShorteningLife Span Shortening
Decrease in average life span documented in Decrease in average life span documented in irradiated animal populationsirradiated animal populations
No unique diseasesNo unique diseases Earlier onsetEarlier onset
Retrospective studies of early radiologistsRetrospective studies of early radiologists Life span shortening of 5 years on averageLife span shortening of 5 years on average
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 6161
Genetic EffectsGenetic Effects
Damage to the genetic material may be Damage to the genetic material may be passed on to future generationspassed on to future generations
Latent periodLatent period
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 6262
MutationsMutations
Spontaneous mutationsSpontaneous mutations Changes in DNA that are not the result of outside Changes in DNA that are not the result of outside
stimulistimuli Permanent and possibly inheritablePermanent and possibly inheritable Examples: Down syndrome, hydrocephalusExamples: Down syndrome, hydrocephalus
Mutation frequencyMutation frequency Number of spontaneous mutations in a generationNumber of spontaneous mutations in a generation
MutagensMutagens Source of mutationSource of mutation Examples: Viruses, chemicals, radiationExamples: Viruses, chemicals, radiation
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 6363
Measuring RiskMeasuring Risk
Doubling doseDoubling dose Unit of measurement for mutation frequencyUnit of measurement for mutation frequency Dose required to double the percentage of Dose required to double the percentage of
mutations in a generationmutations in a generation
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 6464
Studies on Genetic EffectsStudies on Genetic Effects
AnimalAnimal Fruit fliesFruit flies
• Hermann MullerHermann Muller• Determined radiation does not cause unique mutation but Determined radiation does not cause unique mutation but
does increase mutation frequency of spontaneous mutationsdoes increase mutation frequency of spontaneous mutations• No dose thresholdNo dose threshold
Mega-mouse experimentsMega-mouse experiments• Russell and RussellRussell and Russell
HumanHuman Pregnant atomic bomb survivorsPregnant atomic bomb survivors
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 6565
Goal of Radiation TherapyGoal of Radiation Therapy
““Treat the tumor, spare the normal tissue”Treat the tumor, spare the normal tissue” Damage is random and nonspecificDamage is random and nonspecific
Equal probability for normal tissue and tumorEqual probability for normal tissue and tumor Do not typically treat to tumoricidal dosesDo not typically treat to tumoricidal doses
Probability of damage increases as dose Probability of damage increases as dose increasesincreases
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 6666
Therapeutic RatioTherapeutic Ratio
Difference between probability of tumor Difference between probability of tumor control and normal tissue damagecontrol and normal tissue damage
Varies by doseVaries by dose
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 6767
Tumor Cell CharacteristicsTumor Cell Characteristics
Group 1 (P cells)Group 1 (P cells) Well oxygenated and actively proliferatingWell oxygenated and actively proliferating Responsible for growth fraction (GF)Responsible for growth fraction (GF) Most radiosensitiveMost radiosensitive
Group 2 (Q cells)Group 2 (Q cells) Well oxygenated but not proliferatingWell oxygenated but not proliferating In quiescence but may be source of future In quiescence but may be source of future
recurrencerecurrence
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 6868
Tumor Cell CharacteristicsTumor Cell Characteristics
Group 3 (Q cells)Group 3 (Q cells) Hypoxic and not proliferatingHypoxic and not proliferating Most radioresistantMost radioresistant
Group 4 Group 4 Anoxic and necrotic, deadAnoxic and necrotic, dead Not a source of concernNot a source of concern
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 6969
Tumor GrowthTumor Growth Measured in doubling timeMeasured in doubling time
Time required to double total number of cellsTime required to double total number of cells Cell cycleCell cycle
General rule: Tumor cells have a shorter cell cycle General rule: Tumor cells have a shorter cell cycle than normal cellsthan normal cells
Doubling time of 40-100 days vs. 60 days for Doubling time of 40-100 days vs. 60 days for normal cellsnormal cells
Growth fractionGrowth fraction GF = # of P cells / (# of P cells + # of Q cells)GF = # of P cells / (# of P cells + # of Q cells) As GF increases, doubling time decreasesAs GF increases, doubling time decreases
Cell lossCell loss Result of cell death or metastasesResult of cell death or metastases
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 7070
Role of Oxygen in Tumor GrowthRole of Oxygen in Tumor Growth
Tumors eventually outgrow vasculatureTumors eventually outgrow vasculature Central areas of necrosis if tumor is larger than Central areas of necrosis if tumor is larger than
100-180 microns100-180 microns Related to the diffusion distance of oxygen, also Related to the diffusion distance of oxygen, also
known as oxygen tensionknown as oxygen tension Cells closer to the vessel are more Cells closer to the vessel are more
radiosensitiveradiosensitive
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 7171
Tumor RadiosensitivityTumor Radiosensitivity
Varies when total dose to kill tumor is Varies when total dose to kill tumor is consideredconsidered
Varies by tumor cell typeVaries by tumor cell type DD00 used as measurement used as measurement Some postulate that it is the cell’s repair Some postulate that it is the cell’s repair
capabilities not its radiosensitivitycapabilities not its radiosensitivity
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 7272
Normal Tissue Tolerance DoseNormal Tissue Tolerance Dose
Dose at which additional radiation would Dose at which additional radiation would significantly increase probability of severe significantly increase probability of severe normal tissue reactionnormal tissue reaction
Isoeffect curvesIsoeffect curves Tolerance dosesTolerance doses
TDTD50/550/5
• Dose that will cause effect in 50% of population in 5 years Dose that will cause effect in 50% of population in 5 years
TDTD5/55/5
• Dose that will cause effect in 5% of population in 5 yearsDose that will cause effect in 5% of population in 5 years
Based on standard fractionation of 10 Gy/week, Based on standard fractionation of 10 Gy/week, 2 Gy/day, and 5 days/week2 Gy/day, and 5 days/week
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 7373
Time-Dose FractionationTime-Dose Fractionation
The division of the total dose into equal The division of the total dose into equal smaller partssmaller parts
First used in 1927First used in 1927 Sterilized ram testes without skin reactionSterilized ram testes without skin reaction
Less effective than single dose of same sizeLess effective than single dose of same size Also has significantly fewer side effectsAlso has significantly fewer side effects
Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc.Copyright © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. 7474
Factors Affecting Effectiveness Factors Affecting Effectiveness of Fractionationof Fractionation
RedistributionRedistribution Synchronization of surviving cell into resistant Synchronization of surviving cell into resistant
mitotic phasesmitotic phases Normal cells tend to remain in resistant phases, Normal cells tend to remain in resistant phases,
whereas tumor cells enter all phaseswhereas tumor cells enter all phases ReoxygenationReoxygenation
Death of aerobic tumor cells allows hypoxic cells Death of aerobic tumor cells allows hypoxic cells to become more oxygenatedto become more oxygenated
RegenerationRegeneration Occurs between fractions for highly mitotic cellsOccurs between fractions for highly mitotic cells
RepairRepair Cellular repair of sublethal damage (SLD)Cellular repair of sublethal damage (SLD)